Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title: Pilot Study of Acitretin for Treatment of Erlotinib-induced Skin Rash
Brief Summary: This study will look at if a low-dose regimen of acitretin is helpful in treating a skin rash caused by the chemotherapy drug, erlotinib.